Sightstream Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.04M

  • Investors
  • 3

Sightstream General Information

Description

Operator of a biotechnology research company intended to reverse ocular cell death. The company develops cytoprotectives and pro-regenerative technologies that prevent and reverse the death of cells in the ocular cell system, enabling healthcare providers to help patients prevent and recover from ocular cell damage.

Contact Information

Formerly Known As
Kera Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 266 Main Street, Building 2
  • Suite 11
  • Medfield, MA 02052
  • United States
+1 (817)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 266 Main Street, Building 2
  • Suite 11
  • Medfield, MA 02052
  • United States
+1 (817)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sightstream Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 16-Oct-2025 $2.04M Completed Generating Revenue
2. Seed Round 03-Jun-2022 Completed Generating Revenue
1. Merger/Acquisition 25-May-2022 Completed Generating Revenue
To view Sightstream’s complete valuation and funding history, request access »

Sightstream Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-6
Series A-5
Series A-4
Series A-3
Series A-2
Series A-1 5,952,672 $0.000100 8% $0.49 $0.49 1x $0.49 0%
Seed-1 1,225,989 $0.000100 8% $2.65 $2.65 1x $2.65 5.56%
To view Sightstream’s complete cap table history, request access »

Sightstream Patents

Sightstream Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4565258-A2 Compositions for the treatment of disease Pending 03-Aug-2022
EP-4565258-A4 Compositions for the treatment of disease Pending 03-Aug-2022
US-20260151434-A1 Compositions for the treatment of disease Pending 03-Aug-2022
WO-2024030950-A2 Compositions for the treatment of disease Inactive 03-Aug-2022
WO-2024030950-A3 Compositions for the treatment of disease Inactive 03-Aug-2022 A61K35/30
To view Sightstream’s complete patent history, request access »

Sightstream Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sightstream Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
7G Bioventures Venture Capital Minority
Safar Partners Venture Capital Minority
ShangBay Capital Venture Capital Minority
To view Sightstream’s complete investors history, request access »

Sightstream FAQs

  • When was Sightstream founded?

    Sightstream was founded in 2020.

  • Where is Sightstream headquartered?

    Sightstream is headquartered in Medfield, MA.

  • What is the size of Sightstream?

    Sightstream has 7 total employees.

  • What industry is Sightstream in?

    Sightstream’s primary industry is Biotechnology.

  • Is Sightstream a private or public company?

    Sightstream is a Private company.

  • What is the current valuation of Sightstream?

    The current valuation of Sightstream is .

  • What is Sightstream’s current revenue?

    The current revenue for Sightstream is .

  • How much funding has Sightstream raised over time?

    Sightstream has raised $5.11M.

  • Who are Sightstream’s investors?

    7G Bioventures, Safar Partners, and ShangBay Capital have invested in Sightstream.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process